Similarly to the BCR-ABL-transduced CB cells, primary BC CML cells also showed marked proliferative disadvantage upon downregulation of RAC2, with RAC1 depletion having little effect (Fig 1G). This evidence concerns the gene RAC1 and chronic myelogenous leukemia, BCR-ABL1 positive.